Cargando…

Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis

BACKGROUND: Evidence suggests that C-reactive protein (CRP), procalcitonin (PCT), and immune cells can predict sepsis severity in adult patients. However, the specific values of these indicators are not consistent in predicting prognosis. METHODS: A retrospective study analyzed the medical records o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Tian, Wei, Bing, Wang, Junyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265098/
https://www.ncbi.nlm.nih.gov/pubmed/34233608
http://dx.doi.org/10.1186/s12873-021-00477-5
_version_ 1783719701365391360
author Tian, Tian
Wei, Bing
Wang, Junyu
author_facet Tian, Tian
Wei, Bing
Wang, Junyu
author_sort Tian, Tian
collection PubMed
description BACKGROUND: Evidence suggests that C-reactive protein (CRP), procalcitonin (PCT), and immune cells can predict sepsis severity in adult patients. However, the specific values of these indicators are not consistent in predicting prognosis. METHODS: A retrospective study analyzed the medical records of 194 patients based on the concept of sepsis in 2016 (Sepsis 3.0) from January 2017 to December 2019. A comparative analysis of inflammatory factors associated with patients in the sepsis survival and the non-survival group was performed. The concentrations of CRP and PCT, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) were measured. ROC curve was used to assess the diagnosis and analysis of the selected indices of sepsis. According to each index’s cut-off value of the ROC curve, the patients were divided into two groups, and the prognosis was calculated. RESULTS: Among the 194 patients, 32 died (16.49%), the median age of the patients was 79 (66.0, 83.3) years, and 118 were male (60.8%). Analysis of related inflammatory indicators showed that CRP, NLR, MLR, PLR, and CRP*PCT in the non-survival group were statistically higher than those in the survival group (all p values were < 0.05). Regression analysis showed that PCT, CRP, NLR, PLR, and CRP*PCT were all independent prognostic factors for patients. The ROC curve results showed that CRP*PCT had the best diagnostic value (AUC = 0.915). The cut-off values of PCT, CRP, NLR, PLR, MLR, and CRP*PCT were 0.25 ng/mL, 85.00 mg/L, 8.66, 275.51, 0.74%, and 5.85 (mg/L)(2), respectively. Kaplan-Meier survival estimate showed that patient prognosis between the CRP, PCT, NLR, PLR, and CRP*PCT was statistically different (all values P < 0.05, respectively). However, there was no statistically significant difference in gender and MLR (all values P > 0.05, respectively), grouping based on diagnostic cut-off values. CONCLUSIONS: In this study, inflammation-related markers PCT, CRP, NLR, MLR, PLR, and CRP*PCT can be used as independent risk factors affecting the prognosis of patients with sepsis. Furthermore, except for MRL, these indicators have cut-off values for predicting patient death.
format Online
Article
Text
id pubmed-8265098
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82650982021-07-08 Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis Tian, Tian Wei, Bing Wang, Junyu BMC Emerg Med Research Article BACKGROUND: Evidence suggests that C-reactive protein (CRP), procalcitonin (PCT), and immune cells can predict sepsis severity in adult patients. However, the specific values of these indicators are not consistent in predicting prognosis. METHODS: A retrospective study analyzed the medical records of 194 patients based on the concept of sepsis in 2016 (Sepsis 3.0) from January 2017 to December 2019. A comparative analysis of inflammatory factors associated with patients in the sepsis survival and the non-survival group was performed. The concentrations of CRP and PCT, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) were measured. ROC curve was used to assess the diagnosis and analysis of the selected indices of sepsis. According to each index’s cut-off value of the ROC curve, the patients were divided into two groups, and the prognosis was calculated. RESULTS: Among the 194 patients, 32 died (16.49%), the median age of the patients was 79 (66.0, 83.3) years, and 118 were male (60.8%). Analysis of related inflammatory indicators showed that CRP, NLR, MLR, PLR, and CRP*PCT in the non-survival group were statistically higher than those in the survival group (all p values were < 0.05). Regression analysis showed that PCT, CRP, NLR, PLR, and CRP*PCT were all independent prognostic factors for patients. The ROC curve results showed that CRP*PCT had the best diagnostic value (AUC = 0.915). The cut-off values of PCT, CRP, NLR, PLR, MLR, and CRP*PCT were 0.25 ng/mL, 85.00 mg/L, 8.66, 275.51, 0.74%, and 5.85 (mg/L)(2), respectively. Kaplan-Meier survival estimate showed that patient prognosis between the CRP, PCT, NLR, PLR, and CRP*PCT was statistically different (all values P < 0.05, respectively). However, there was no statistically significant difference in gender and MLR (all values P > 0.05, respectively), grouping based on diagnostic cut-off values. CONCLUSIONS: In this study, inflammation-related markers PCT, CRP, NLR, MLR, PLR, and CRP*PCT can be used as independent risk factors affecting the prognosis of patients with sepsis. Furthermore, except for MRL, these indicators have cut-off values for predicting patient death. BioMed Central 2021-07-07 /pmc/articles/PMC8265098/ /pubmed/34233608 http://dx.doi.org/10.1186/s12873-021-00477-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Tian, Tian
Wei, Bing
Wang, Junyu
Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis
title Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis
title_full Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis
title_fullStr Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis
title_full_unstemmed Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis
title_short Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis
title_sort study of c-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265098/
https://www.ncbi.nlm.nih.gov/pubmed/34233608
http://dx.doi.org/10.1186/s12873-021-00477-5
work_keys_str_mv AT tiantian studyofcreactiveproteinprocalcitoninandimmunocyteratiosin194patientswithsepsis
AT weibing studyofcreactiveproteinprocalcitoninandimmunocyteratiosin194patientswithsepsis
AT wangjunyu studyofcreactiveproteinprocalcitoninandimmunocyteratiosin194patientswithsepsis